Annika, a 28-year-old from California, was diagnosed with a rare nasal cancer The cancer, sinonasal carcinoma SMARCB1, has only been seen in 200 patients READ MORE: I'm the first person in the ...
Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...